MONSTAR LAB, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 316 JPY | -2.17% |
|
-10.23% | +12.06% |
| 05-08 | EVisit, Inc. and Monstarlab Holdings Inc. Forge Strategic Alliance to Revolutionize Virtual Care Platforms | CI |
| 03-29 | Monstarlab Holdings Unveils New Leadership | MT |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 9,680 |
| Enterprise Value (EV) 1 | 14,972 |
| P/E ratio | -4.02 x |
| Yield | - |
| Capitalization / Revenue | 0.73 x |
| EV / Revenue | 1.12 x |
| EV / EBITDA | -5,850,801 x |
| EV / FCF | -11,888,595 x |
| FCF Yield | -0% |
| Price to Book | 2.61 x |
| Nbr of stocks (in thousands) | 34,327 |
| Reference price 2 | 282.0 |
| Announcement Date | 28/03/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 7,419 | 9,346 | 14,270 | 13,346 |
| EBITDA | - | - | - | -2,559 |
| EBIT 1 | -1,502 | -3,223 | -389 | -2,995 |
| Operating Margin | -20.25% | -34.49% | -2.73% | -22.44% |
| Earnings before Tax (EBT) 1 | -1,548 | -3,089 | -446 | -2,157 |
| Net income 1 | -1,274 | -3,053 | -674 | -2,355 |
| Net margin | -17.17% | -32.67% | -4.72% | -17.65% |
| EPS 2 | -2,794 | -113.2 | -24.51 | -70.07 |
| Free Cash Flow | - | - | - | -1,259 |
| FCF margin | - | - | - | -9.44% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 24/02/23 | 24/02/23 | 24/02/23 | 28/03/24 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 |
|---|---|---|---|---|
| Net sales 1 | 3,638 | 6,760 | 3,350 | 3,179 |
| EBITDA | - | - | - | - |
| EBIT 1 | 353 | -468 | -1,026 | -891 |
| Operating Margin | 9.7% | -6.92% | -30.63% | -28.03% |
| Earnings before Tax (EBT) 1 | 251 | 123 | -1,019 | -268 |
| Net income 1 | 197 | 7 | -1,097 | -340 |
| Net margin | 5.42% | 0.1% | -32.75% | -10.7% |
| EPS 2 | 6.210 | 0.2300 | -32.91 | -9.920 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 15/05/23 | 14/08/23 | 14/11/23 | 15/05/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 63 | - | 2,148 | 5,292 |
| Net Cash position 1 | - | 620 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -2.068 x |
| Free Cash Flow | - | - | - | -1,259 |
| ROE (net income / shareholders' equity) | - | -95.4% | -19.5% | -59.5% |
| ROA (Net income/ Total Assets) | - | -20.6% | -2.13% | -13.7% |
| Assets 1 | - | 14,840 | 31,646 | 17,225 |
| Book Value Per Share 2 | 5,991 | 126.0 | 145.0 | 108.0 |
| Cash Flow per Share 2 | 7,663 | 142.0 | 85.90 | 51.90 |
| Capex | - | - | - | 121 |
| Capex / Sales | - | - | - | 0.91% |
| Announcement Date | 24/02/23 | 24/02/23 | 24/02/23 | 28/03/24 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +12.06% | 70.99M | |
| -17.07% | 183B | |
| +0.98% | 163B | |
| +2.34% | 154B | |
| +5.50% | 101B | |
| +14.53% | 83.86B | |
| +34.02% | 83.27B | |
| -4.58% | 71.02B | |
| -32.52% | 44.96B | |
| -4.68% | 43.63B |
- Stock Market
- Equities
- 5255 Stock
- Financials Monstar Lab, Inc.